PETRI DISH PERSPECTIVES

PETRI DISH PERSPECTIVES

Download on the App Store

PETRI DISH PERSPECTIVES episodes

  • Episode 23: Alnylam

    Send us Fan Mail

    What if you could silence disease at its genetic root? That was the bold promise behind RNA interference (RNAi), one of the most groundbreaking scientific discoveries of the 21st century.

    In this episode, we dive into the story of Alnylam Pharmaceuticals, from its founding by a powerhouse team of Nobel laureates, pioneering scientists, and biotech visionaries, to its transformation into the world’s first RNAi therapeutics company. We explore the challenges of turning a fragile lab discovery into medicine, the blockbuster drugs that redefined rare disease treatment, and the people who made it all possible.

    Whether you’re a biotech enthusiast, a student of innovation, or just curious about how cutting-edge science becomes lifesaving therapy, this episode will take you inside the revolution that gave rise to RNAi medicines.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #BiotechUnleashed #Alnylam #RNAi #BiotechPodcast #RareDisease #DrugDiscovery #BiotechHistory #GeneticMedicine

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    24 min
  • Episode 22: Takeda

    Send us Fan Mail

    From its humble beginnings in 1781 as a family-run herbal medicine shop in Osaka to becoming one of the world’s top 10 pharmaceutical companies, Takeda’s story is one of resilience, reinvention, and bold transformation.

    In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead unpacks Takeda’s 240-year journey, from the vision of founder Chobei Takeda, through the blockbuster eras of Prevacid and Actos, to the game-changing acquisition of Shire under CEO Christophe Weber. We’ll dive into the discovery stories behind Takeda’s most important drugs, the leaders who left their mark, and the lessons this Japanese giant offers on balancing tradition with global ambition.

    Whether you’re fascinated by pharma history, curious about blockbuster drug stories, or want to understand how one company bridged centuries of medicine, this episode has it all.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #Takeda #BiotechPodcast #PharmaHistory #DrugDiscovery #HealthcareInnovation #RareDiseases #BiotechUnleashed #PetriDishPerspectives

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    25 min
  • Episode 21: Moderna

    Send us Fan Mail

    From secrecy and skepticism to one of the fastest vaccine rollouts in history, this episode of Petri Dish Perspectives: Biotech Unleashed dives into the remarkable journey of Moderna. We trace the company’s early hype, billion-dollar partnerships, and criticism for overpromising, through to its historic COVID-19 vaccine that changed global medicine. What’s next for Moderna beyond the pandemic? Tune in to explore how one biotech bet on mRNA and won.

    Whether you’re a biotech enthusiast, a healthcare professional, or just curious about the companies that quietly keep hospitals running, this episode sheds light on why Moderna deserves your attention.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #Moderna #mRNA #BiotechUnleashed #PetriDishPerspectives #COVID19Vaccine #Biotech #Pharma #DrugDevelopment #Innovation #Healthcare #Vaccines

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    25 min
  • Episode 20: Baxter

    Send us Fan Mail

    Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia therapies, and parenteral nutrition, Baxter has consistently solved medicine’s “unsexy but essential” problems.

    In this episode, we dive into the company’s origins, explore the backstories of its most important innovations, and trace how it spun off biotech powerhouse Baxalta, later snapped up by Shire and Takeda. Along the way, we highlight the people who left their mark and extract key lessons from Baxter’s journey through growth, crisis, and reinvention.

    Whether you’re a biotech enthusiast, a healthcare professional, or just curious about the companies that quietly keep hospitals running, this episode sheds light on why Baxter deserves your attention.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    Hashtags:
    #BiotechUnleashed #PetriDishPerspectives #Baxter #BiotechHistory #HealthcareInnovation #Biopharma #LifeSciences #DrugDiscovery #MedicalDevices #PharmaIndustry

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    24 min
  • Episode 19: AstraZeneca

    Send us Fan Mail

    In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health. 

    Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transformed AstraZeneca into one of today’s most innovative pharmaceutical giants.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #AstraZeneca #BiotechUnleashed #PetriDishPerspectives #BiotechPodcast #PharmaInnovation #Oncology #CardiometabolicHealth #PrecisionMedicine #DrugDiscovery #HealthcareLeadership

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    24 min
  • Episode 18: Gilead

    Send us Fan Mail

    In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health with a cure for hepatitis C, and pushed into oncology with cutting-edge CAR-T therapies.

    But alongside these triumphs came firestorms of criticism, from the $84,000 price tag of Sovaldi to debates around HIV drug access and patents. Gilead has long walked the fine line between lifesaving innovation and public outrage, forcing society to wrestle with the question: What is the true price of a cure?

    Join us as we unpack Gilead’s origins, its blockbuster breakthroughs, its controversies, and what lies ahead for one of biotech’s most influential and polarizing companies.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #Biotech #GileadSciences #HIV #HepatitisC #CART #Oncology #DrugDiscovery #Pharma #HealthcareInnovation #MedicalBreakthroughs #PetriDishPerspectives

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    25 min
  • Episode 17: GSK

    Send us Fan Mail

    In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants!

    From scaling up penicillin production in WWII, to pioneering semi-synthetic antibiotics like amoxicillin, to leading the global vaccine race with Cervarix and Shingrix, GSK has left an indelible mark on modern medicine. We also explore its groundbreaking role in HIV treatment through ViiV Healthcare, and the blockbuster drugs that reshaped respiratory and infectious disease care. Along the way, we draw key lessons on adaptability, collaboration, and the power of prevention in pharma’s evolving landscape.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #GSK #Pharma #Vaccines #BiotechPodcast #DrugDiscovery #HIV #Shingrix #Cervarix #Antibiotics #Asthma #PetriDishPerspectives

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    25 min
  • Episode 16: Amgen

    Send us Fan Mail

    In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive deep into the origin story of Amgen, a company that helped turn “biotechnology” from a niche lab concept into a global medical force.

    We’ll trace Amgen’s unlikely beginnings in 1980, a time when gene splicing was still the stuff of scientific legend and meet the eclectic founding team: George Rathmann, the charismatic chemist-turned-executive; Winston Salser, the UCLA scientist eager to bring basic research to patients; Bill Bowes, the venture capitalist who had already bet big on Genentech; and Ray Schinazi, the young medicinal chemist destined to become an antiviral pioneer.

    From its scrappy early days in Thousand Oaks to its first blockbuster drugs like Epogen and Neupogen, Amgen’s story is one of scientific daring, boardroom brinkmanship, and relentless pursuit of innovation. We’ll explore the company’s pivotal moments, the personalities who shaped its path, and how it helped define the modern biotech industry.

    Whether you’re a biotech insider, a science history buff, or just curious about how life-saving drugs make it from idea to reality, this is one you won’t want to miss.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #Amgen #BiotechHistory #PharmaInnovation #DrugDiscovery #BiotechPodcast #ScienceStorytelling #Biotechnology #HealthcareInnovation #LifeSciences #PetriDishPerspectives #BiotechUnleashed

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    27 min
  • Episode 15: BGI Genomics

    Send us Fan Mail

    What happens when one of the world’s most powerful genomics companies rises from a college dorm in China and goes on to challenge the West’s biotech dominance? In this episode of Petri Dish Perspectives: Biotech Unleashed, we unravel the story of BGI Genomics, a company at the intersection of cutting-edge science, national ambition, and global controversy.

    From decoding the human genome to building the world’s largest sequencing fleet, BGI’s journey is as bold as it is complex. We’ll explore the vision of its founders, its scientific breakthroughs in synthetic biology and population-scale genomics, its collaborations and tensions with Western partners, and the ethical debates surrounding its work in data privacy and government-backed research.

    Whether you're in biotech, healthcare, or just fascinated by the future of science, this episode dives into how BGI is reshaping medicine, research, and geopolitics and what we can all learn from its rise.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #BGIGenomics #Genomics #ChinaBiotech #BiotechPodcast #DNASequencing #SyntheticBiology #PetriDishPerspectives #BiotechUnleashed #Bioethics #GlobalHealth #PrecisionMedicine #HumanGenomeProject #BGI

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    24 min
  • Episode 14: Abbott

    Send us Fan Mail

    In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you inside the remarkable story of Abbott Laboratories: a company that doesn’t chase headlines but touches billions of lives every day.

    From its origins in 1888 as a small Chicago pharmacy mixing precise plant-based pills, Abbott has grown into a global healthcare powerhouse behind life-changing products like the FreeStyle Libre glucose monitor, BinaxNOW COVID-19 tests, Similac baby formula, Ensure nutrition shakes, and cutting-edge heart devices.

    You’ll hear how a frontier doctor’s mission for safer, more reliable medicine sparked 135+ years of steady, practical innovation, from mass-producing penicillin in WWII to pioneering rapid diagnostics in a pandemic. You’ll also learn how Abbott’s global workforce and patient-first mindset continue to solve everyday health challenges in ways that quietly shape our world.

    Grab your coffee, settle in for under 30 minutes, and discover why Abbott proves that sometimes the most powerful biotech breakthroughs aren’t flashy moonshots, they’re the everyday tools that keep us living longer, healthier, and freer lives.

    🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

    https://linktr.ee/maneadkhin

    #Biotech #HealthcareInnovation #Abbott #PetriDishPerspectives #SciencePodcast #MedicalDevices #Diagnostics #GlucoseMonitoring #NutritionScience #HealthTech #LifeSciences #PodcastRecommendation

    Support the show

    © 2026 The Perspective Bureau LLC. All rights reserved.

    25 min

About PETRI DISH PERSPECTIVES

From the publisher's feed

Burma | Chicago
Scientist 🥼🧪🔬
Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎

Stream new episodes every…